ABSTRACT OBJECTIVES This study aimed to determine the rate and extent of plaque progression (PP), changes in plaque features, and clinical predictors of PP in patients with diabetes mellitus (DM).
The study design of the registry has been described in detail previously (9) . The study population includes 2,252 adults who underwent serial coronary CTA over a period of at least 24 months at 13 cardiovascular centers. Of the initial 2,252 patients, a total of 1, 602 were included in the present study owing to exclu- (10, 11) . Among these 492 patients, follow-up coronary CTA scans were also noninterpretable in 385 patients.
A total of 372 subjects with DM were identified. A remodeling index threshold of $1.1 was suggested as PR (15) .
LONGITUDINAL ANALYSIS OF PLAQUE FEATURES.
Differences and percent changes in parameters measured from baseline and follow-up coronary CTA were used for longitudinal analysis of coronary artery plaque morphology and composition (16) .
The difference in parameters between baseline and Table 2 ).
STATISTICAL ANALYSIS. Previous studies demonstrated excellent intraobserver and interobserver reproducibility in coronary CTA imaging analysis protocol and methodology of the core laboratory, validated against IVUS as a gold standard (17, 18) .
Continuous variables were expressed as mean AE SD.
Variables were compared with chi-square test for categorical variables and independent sample Student's t-test for continuous variables. If dependent variables were not normally distributed, the MannWhitney U test was used to compare differences be- 
RESULTS
BASELINE CHARACTERISTICS. Baseline characteristics of the entire cohort are shown in Table 1 . Patients Abbreviations as in Tables 1 and 2 . Variables for univariate analysis in nonmatched cohorts were age, DM, hypertension, current smoking, medication use (aspirin, beta-blocker, ACE inhibitor/ARB, statin) at baseline, LDL at baseline, HbA1c at baseline, plaque volume at baseline, and mean plaque burden at baseline. Variables for univariate analysis in patients with DM were age, male, current smoker, LDL level, HbA1c, plaque volume at baseline coronary CTA, and mean plaque burden at baseline coronary CTA.
CI ¼ confidence interval; OR ¼ odds ratio; other abbreviations as in Table 1 .
Natural History of Diabetic Coronary Atherosclerosis Table 1 ).
HRP FEATURES IN MATCHED PATIENTS WITH
VERSUS WITHOUT DM. At baseline, there was no significant difference in the proportion of patients with and without DM who had LAP (Figure 2A (Figure 3) . Values are mean AE SD.
Abbreviations as in Table 1 .
Kim et al. Table 2 ). IVUS studies also have shown that abnormal glucose Figure 1 .
Natural History of Diabetic Coronary Atherosclerosis College of Cardiology/American Heart Association guidelines recommend LDL levels below 70 mg/dl for patients with DM and CAD because they are considered a high-risk group (28) . Our data support these recommendations, which suggests that strategies to decrease LDL levels below 70 mg/dl as a treatment target could be necessary to help reduce PP.
As well, our study showed that tight glycemic control with lower HbA 1c levels in DMþ patients was associated with a greater likelihood of plaque stabilization. Although further studies are needed to confirm our findings, these data are potentially quite informative not only to guide treatment strategy but also perhaps as a tool to assist with patient adherence to lifestyle modification.
STUDY LIMITATIONS. There are limitations of our study. First, the PARADIGM trial was designed in a Values are mean AE SD or n (%).
Abbreviations as in Table 1 . 
